HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ling-Long Tang Selected Research

Inflammation (Inflammations)

3/2016Primary tumor inflammation in gross tumor volume as a prognostic factor for nasopharyngeal carcinoma patients.
1/2016Exploration and Validation of C-Reactive Protein/Albumin Ratio as a Novel Inflammation-Based Prognostic Marker in Nasopharyngeal Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ling-Long Tang Research Topics

Disease

121Nasopharyngeal Carcinoma
03/2024 - 11/2004
30Neoplasms (Cancer)
12/2023 - 02/2006
20Neoplasm Metastasis (Metastasis)
01/2023 - 02/2006
7Lymphatic Metastasis
12/2017 - 07/2007
5Neutropenia
01/2021 - 11/2016
4Carcinogenesis
01/2023 - 10/2013
4Infections
01/2023 - 01/2014
4Necrosis
01/2022 - 11/2008
3Vomiting
01/2022 - 11/2018
3Nausea
01/2022 - 11/2018
3Hypothyroidism
01/2020 - 11/2018
3Mucositis
05/2018 - 03/2017
3Stomatitis
12/2017 - 02/2012
2Extranodal Extension
01/2023 - 01/2022
2Lung Neoplasms (Lung Cancer)
01/2023 - 11/2018
2Fatigue
01/2023 - 01/2022
2Squamous Cell Carcinoma of Head and Neck
06/2022 - 12/2017
2Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
10/2019 - 01/2016
2Anemia
01/2019 - 12/2017
2Xerostomia
03/2017 - 10/2015
2Inflammation (Inflammations)
03/2016 - 01/2016
2Atrophy
12/2015 - 08/2015
1Bites and Stings (Sting)
06/2023
1Melanoma (Melanoma, Malignant)
01/2023
1COVID-19
10/2022
1Disease Progression
01/2022
1Sleep Initiation and Maintenance Disorders (Insomnia)
01/2022
1Optic Nerve Diseases (Optic Neuropathy)
01/2022
1Pain (Aches)
01/2022
1Dermatomyositis (Dermatopolymyositis)
01/2022
1Constipation
01/2022
1Residual Neoplasm
01/2022
1Hand-Foot Syndrome
01/2021
1Thrombocytopenia (Thrombopenia)
01/2019
1Pneumonia (Pneumonitis)
11/2018
1Arthralgia (Joint Pain)
11/2018
1Carcinoma (Carcinomatosis)
03/2018
1Head and Neck Neoplasms (Head and Neck Cancer)
12/2017
1Spasm (Spasms)
11/2017
1Leukopenia
03/2017
1Hearing Loss (Hearing Impairment)
03/2017

Drug/Important Bio-Agent (IBA)

24DNA (Deoxyribonucleic Acid)IBA
11/2023 - 01/2015
15Cisplatin (Platino)FDA LinkGeneric
06/2023 - 02/2012
10Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2014
4GemcitabineFDA Link
06/2023 - 01/2019
4Fluorouracil (Carac)FDA LinkGeneric
01/2019 - 02/2012
3Messenger RNA (mRNA)IBA
01/2023 - 01/2018
3Immune Checkpoint InhibitorsIBA
11/2021 - 11/2018
3MicroRNAs (MicroRNA)IBA
06/2020 - 10/2013
3Docetaxel (Taxotere)FDA Link
01/2019 - 11/2016
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2023 - 01/2021
2PlatinumIBA
06/2022 - 01/2019
2nitazoxanide (NTZ)FDA Link
05/2018 - 01/2018
2ErbB Receptors (EGF Receptor)IBA
05/2018 - 01/2018
2Cetuximab (Erbitux)FDA Link
01/2018 - 01/2018
2nimotuzumabIBA
01/2018 - 01/2018
2AlbuminsIBA
01/2016 - 01/2014
2GlobulinsIBA
01/2016 - 01/2014
2Serum AlbuminIBA
11/2015 - 01/2014
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
09/2013 - 03/2012
1Transcription Factors (Transcription Factor)IBA
01/2024
1Circular RNAIBA
12/2023
1Interferon Type IIBA
06/2023
1Toll-Like Receptor 9IBA
06/2023
1N-methyladenosineIBA
01/2023
16-methyladenineIBA
01/2023
1Glutathione (Reduced Glutathione)IBA
06/2022
1Carrier Proteins (Binding Protein)IBA
06/2022
1TOR Serine-Threonine KinasesIBA
06/2022
1Insulin-Like PeptidesIBA
06/2022
1GlycosphingolipidsIBA
06/2022
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
06/2022
1Peptide Initiation Factors (Initiation Factor)IBA
06/2022
1Long Noncoding RNAIBA
01/2022
1apatinibIBA
01/2022
116S Ribosomal RNAIBA
01/2022
1Angiogenesis InhibitorsIBA
01/2022
1Capecitabine (Xeloda)FDA Link
01/2021
1CortactinIBA
01/2020
1Tumor Biomarkers (Tumor Markers)IBA
12/2018
1NivolumabIBA
11/2018
1atezolizumabIBA
11/2018
1pembrolizumabIBA
11/2018
1Monoclonal AntibodiesIBA
01/2018
1Antiviral Agents (Antivirals)IBA
09/2017
1EnzymesIBA
09/2017
1Uric Acid (Urate)IBA
01/2017
1Serum GlobulinsIBA
01/2016
1C-Reactive ProteinIBA
01/2016

Therapy/Procedure

47Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2024 - 07/2007
41Radiotherapy
03/2024 - 02/2006
29Chemoradiotherapy
03/2024 - 08/2008
27Induction Chemotherapy
01/2024 - 11/2016
21Drug Therapy (Chemotherapy)
12/2023 - 08/2008
18Therapeutics
01/2024 - 01/2015
6Adjuvant Chemotherapy
01/2021 - 08/2008
5Aftercare (After-Treatment)
01/2022 - 03/2012
5Neoadjuvant Therapy
03/2017 - 01/2015
3Immunotherapy
01/2022 - 09/2017
1Lasers (Laser)
12/2017